M&T will be engaged in health and Biomedical, high impact sectors of the health care and our integrated capabilities span the entire spectrum of ‘design to deliver’. We have a strong, customer focused approach and a continuous quest for world-class quality, we will develop unmatched expertise across health technology in Biomedical, and Telemedicine fields all our major lines of business
CRISPR editing of genomic regulatory elements with the intention of direct exon/intron splicing is a hopeful means of everlastingly alleviating genetic diseases. Cas9-induced DNA double-stranded break, non-homologous end-joining repair pathways frequently introduce variable indel mutations at the cut site. Circadian rhythms control cell proliferation and differentiation, however circadian control of Human induced pluripotent stem cells (hiPSCs) remains study at the molecular level
Meet the Team
Saidulu Mattapally
Chandrakala Mattapally
Away from home: Using science for societal good
Next Steps…
Call to Action